Olive compound could spark brown fat to fight obesity
NCT ID NCT06484543
First seen Apr 11, 2026 · Last updated Jun 22, 2026 · Updated 13 times
Summary
This study tests whether maslinic acid, a natural compound found in olive skins, can improve metabolic health by activating brown fat—a type of fat that burns calories. Fifty adults with pre-metabolic syndrome or mild obesity will take maslinic acid or a placebo for 12 weeks. Researchers will measure changes in blood sugar, body fat, energy use, and other markers of metabolic health.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Singapore Institute of Clinical Sciences
Singapore, Singapore
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Maslinic acid (a natural compound found in olive skins and other plants)
What this could lead to
If it works, this could point toward a simple, natural supplement to help manage obesity and related metabolic problems like insulin resistance.
What could go wrong
This is an early-stage trial with only 50 participants, all of Chinese ethnicity, so results may not apply to everyone. The compound is a nutraceutical, not a drug, so effects may be modest.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.